Skip to content

MCK

MCKESSON CORP

NYSE · Healthcare · Medical - Distribution · US

$994.58
+1.40%
Ask drillr
  • Oct 21, 2026, 22:51 UTC

    MCKESSON CORP shares fell 1.42% to $1 on the latest trading day.

    Source:
  • Oct 20, 2026, 23:01 UTC

    MCKESSON CORP shares closed at $1, up 1.95% from the previous trading session.

    Source:
  • Oct 14, 2026, 23:01 UTC

    MCKESSON CORP shares closed at $976.57, up 1.53% from the previous close.

    Source:
  • Oct 8, 2026, 20:34 UTC

    Option Care Health is the subject of a proposed sale to Clayton Dubilier & Rice LLC and MCKESSON CORP for $32.05 per share in cash.

  • Oct 6, 2026, 15:23 UTC

    Halper Sadeh LLC announced an investigation into whether Option Care Health's sale to CD&R and McKesson Corporation at $32.05 per share obtains a fair price for shareholders.

  • Oct 6, 2026, 12:33 UTC

    CD&R and McKesson agreed to acquire Option Care Health in a $5.8 billion takeover, sending OPCH shares up 34%.

  • Oct 5, 2026, 20:01 UTC

    McKesson and Clayton, Dubilier & Rice are near a deal worth more than $5bn to acquire infusion services provider Option Care Health.

  • Oct 1, 2026, 12:03 UTC

    McKesson Corporation signed an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032.

  • Sep 30, 2026, 23:00 UTC

    McKesson (MCK) shares fell 1.27% to close at $853.81, a larger decline than the broader market.

    Source:
  • Sep 23, 2026, 23:00 UTC

    McKesson (MCK) shares fell 1.2% to settle at $880.50, underperforming the broader market.

    Source:
  • Sep 23, 2026, 12:00 UTC

    McKesson Corporation announced it will release its second quarter fiscal 2027 financial results after market close on November 4, 2026, with a conference call at 4:30 PM Eastern Time.

  • Sep 11, 2026, 15:59 UTC

    A Texas federal district court denied McKesson Corporation's motion for summary judgment on a former senior director's Family and Medical Leave Act retaliation claim.

  • Aug 31, 2026, 21:39 UTC

    McKesson disclosed a cyberattack that resulted in data theft and temporary service interruptions, affecting a subset of customers in its oncology, multispecialty, and medical-surgical business units.

  • Aug 31, 2026, 13:14 UTC

    McKesson confirmed a data breach after the ShinyHunters extortion group claimed to have stolen 284 million records from its systems.

  • Aug 25, 2026, 12:17 UTC

    McKesson agreed to acquire Precision Medicine Group for approximately $2.25 billion.

  • Aug 17, 2026, 09:40 UTC

    Focus Partners Advisor Solutions LLC acquired a new stake of 1,702 shares in McKesson Corporation, valued at approximately $1.29 million, during the second quarter, as disclosed in a Form 13F filing.

  • Aug 15, 2026, 07:30 UTC

    BIP Wealth LLC acquired a new stake in McKesson Corporation by purchasing 2,314 shares valued at approximately $1.75 million, as disclosed in its Form 13F filing.

  • Aug 5, 2026, 23:01 UTC

    McKesson reported its financial results for the quarter ended June 2026.

  • Jul 23, 2026, 10:45 UTC

    RH appointed Ryan Hassanein as Chief Legal & Compliance Officer.

  • Jul 1, 2026, 00:00 UTC

    Thomas L. Rodgers will retire as Executive Vice President, Chief Strategy and Business Development Officer of McKesson Corp effective August 1, 2026, and Ramesh Srinivasan will succeed him as Executive Vice President, Chief Strategy Officer.

  • Jun 23, 2026, 20:00 UTC

    McKesson Corporation selected Moore, Oklahoma as the location for a new highly automated regional distribution facility at the North Moore Industrial Park, replacing an existing center and expanding capacity.

  • Jun 12, 2026, 00:00 UTC

    McKesson Corp amended its credit agreement to add a new $2.25 billion senior secured term B loan facility due 2032, bearing interest at Adjusted Term SOFR plus 2.25% or Base Rate plus 1.25%.

  • Jun 3, 2026, 22:54 UTC

    McKesson Medical-Surgical Top Holdings Inc., a unit of McKesson Corp., priced a $2.25 billion leveraged loan on Wednesday ahead of its planned IPO.